Title |
HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability
|
---|---|
Published in |
BMC Infectious Diseases, April 2012
|
DOI | 10.1186/1471-2334-12-100 |
Pubmed ID | |
Authors |
Jean Ruelle, Laurent Debaisieux, Ellen Vancutsem, Annelies De Bel, Marie-Luce Delforge, Denis Piérard, Patrick Goubau |
Abstract |
Current real-time PCR-based HIV-1 viral load (VL) assays allow the detection of residual viraemia in antiretroviral-treated patients. The clinical outcome of HIV1 patients experiencing low-level replication (<50 cop/mL) in comparison with fully suppressed patients is currently debated. We analysed variability of 3 VL assays <50 cop/mL, and evaluated the reproducibility of viral blips <100 cop/mL. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 40% |
Canada | 1 | 20% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 2% |
Unknown | 41 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 11 | 26% |
Student > Ph. D. Student | 6 | 14% |
Student > Bachelor | 5 | 12% |
Student > Doctoral Student | 3 | 7% |
Researcher | 3 | 7% |
Other | 8 | 19% |
Unknown | 6 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 45% |
Agricultural and Biological Sciences | 8 | 19% |
Immunology and Microbiology | 6 | 14% |
Biochemistry, Genetics and Molecular Biology | 1 | 2% |
Nursing and Health Professions | 1 | 2% |
Other | 2 | 5% |
Unknown | 5 | 12% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2012.
All research outputs
#13,129,127
of 22,664,644 outputs
Outputs from BMC Infectious Diseases
#3,142
of 7,636 outputs
Outputs of similar age
#89,701
of 163,178 outputs
Outputs of similar age from BMC Infectious Diseases
#35
of 96 outputs
Altmetric has tracked 22,664,644 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,636 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,178 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.